Diminished Susceptibility to Cefoperazone/Sulbactam and Piperacillin/Tazobactam in Enterobacteriaceae Due to Narrow-Spectrum β-Lactamases as Well as Omp Mutation

Yang, Fengzhen; Zhao, Qi; Wang, Lipeng; Wu, Jinying; Jiang, Lihua; Sheng, Li; Zhang, Leyan; Xue, Zhaoping; Yi, Maoli

doi:10.33073/pjm-2022-023

Abstract

Cefoperazone/sulbactam (CSL) and piperacillin/tazobactam (TZP) are commonly used in clinical practice in China because of their excellent antimicrobial activity. CSL and TZP-nonsusceptible Enterobacteriaceae are typically resistant to extended-spectrum cephalosporins such as ceftriaxone (CRO). However, 11 nonrepetitive Enterobacteriaceae strains, which were resistant to CSL and TZP yet susceptible to CRO, were collected from January to December 2020. Antibiotic susceptibility tests and whole-genome sequencing were conducted to elucidate the mechanism for this rare phenotype. Antibiotic susceptibility tests showed that all isolates were amoxicillin/clavulanic-acid resistant and sensitive to ceftazidime, cefepime, cefepime/tazobactam, cefepime/zidebactam, ceftazidime/avibactam, and ceftolozane/tazobactam. Whole-genome sequencing revealed three of seven Klebsiella pneumoniae strains harbored bla_SHV-1 only, and four harbored bla_SHV-1 and bla_TEM-1B. Two Escherichia coli strains carried bla_TEM-1B only, while two Klebsiella oxytoca isolates harbored bla_OXY-1-3 and bla_OXY-1-1, respectively. No mutation in the β-lactamase gene and promoter sequence was found. Outer membrane protein (Omp) gene detection revealed that numerous missense mutations of OmpK36 and OmpK37 were found in all strains of K. pneumoniae. Numerous missense mutations of OmpK36 and OmpK35 and OmpK37 deficiency were found in one K. oxytoca strain, and no OmpK gene was found in the other. No Omp mutations were found in E. coli isolates. These results indicated that narrow spectrum β-lactamases, TEM-1, SHV-1, and OXY-1, alone or in combination with Omp mutation, contributed to the resistance to CSL and TZP in CRO-susceptible Enterobacteriaceae.

Antibiotic susceptibility tests

Antibiotics	Breakpoint, (μg/ml)	Klebsiella pneumoniae							Escherichia cou		Klebriehd axyoca
Antibiotics	Breakpoint, (μg/ml)	E1	E3	E4	E7	E9	E10	E11	E6	E8	E2	E5
CRO	≤1≥4	≤0.5	≤0.5	≤0.5	≤0.5 1		≤0.5	1	≤0.5	≤0.5	1	1
CAZ	4 ≥16	1	2	1	4	4	4	4	2	4	1 1
FEP	≤2 216 1	1		0.25	1	2	2	2	0.5	2	1 1
AMC	≤8 ≥32	≥128	≥128	≥128	≥128	≥128	≥128	≥128	≥128	≥128	≥128	≥128
CSL	≤16 ≥64	64	64	64	64	≥128	128	≥128	64	128	128	≥128
TZP	≤16 ≥128	≥256	≥256	≥256	≥256	2256	2256	≥256	≥256	≥256	≥256	≥256
FPT	≤2 ≥16	1	0.5	0.06	0.125	2	1	2	0.25	1	0.125	0.25
FPZ	≤2 216	0.25	0.25	0.06	0.125	0.25	0.25 1		0.125	0.25	0.125	0.125
CZA	≤8 216 1		0.5	0.25	0.25	1	0.25	1	0.5	0.5	0.5	0.25
CZT	≤2 28	2	1	0.5 1		2	2	2 1		1	2	2

CROceftriaxone, CAZceftazidime, FEPcefepime, AMC:amoxicillin clavulanic-acid, CSLcefoperazone/sulbactam, TZP:piperadllin/tazobactam, FPT:cefepime tazobactam, FPZ:cefepime/zidebactam, CZA:ceftazidime/avibactam, CZTceftolozane/tazobactam

Gene sequencing results

Number	Strain	ST	p-Lactamase gene	Promoter sequence mutation	Omp mutation
El	Kpn	45	blaSHV-1, blaTEM-lB	none	OmpK36, OmpK3 7
E3	Kpn	45	blaSHV-1, blaTEM-lB	none	OmpK36. OmpK3 7
E4	Kpn	2854	blaSHV-1	none	OmpK36, OmpK3 7
E7	Kpn	2358	blaSHV-1 - blaTEM-lB	none	OmpK36, OmpK3 7
E9	Kpn	2358	blaSHV-1. blaTEM-lB	none	OmpK36. OmpK3 7
E10	Kpn 18	9	blaSHV-1	none	OmpK36. OmpK3 7
Ell	Kpn	45	blaSHV-1	none	OmpK36, OmpK3 7
E6	Eco	88	blaTEM-lB	none	none
ES	Eco	409	blaTEM-1B	none	none
E2	Kox	194	blaOXY-1-3	none	OmpK36 mutations. OmpK35 and OmpK 37 deficiency
E5	Kox 11		blaOXY-1-1	none	no OmpK (OmpK3 5, OmpK36 and OmpK37) gene found

References

Aihara M, Nishida R, Akimoto M, Gotoh Y, Kiyosuke M, Uchiumi T, Nishioka M, Matsushima Y, Hayashi T, Kang D. Within-host evolution of a Klebsiella pneumoniae clone: selected mutations associated with the alteration of outer membrane protein expression conferred multidrug resistance. J Antimicrob Chem-other. 2021 Jan 19;76(2):362–369. https://doi.org/10.1093/jac/dkaa439
Open DOI Search in Google Scholar Back to article
Bafna JA, Sans-Serramitjana E, Acosta-Gutiérrez S, Bodrenko IV, Hörömpöli D, Berscheid A, Brötz-Oesterhelt H, Winterhalter M, Ceccarelli M. Kanamycin uptake into Escherichia coli is facilitated by OmpF and OmpC porin channels located in the outer membrane. ACS Infect Dis. 2020 Jul 10;6(7):1855–1865. https://doi.org/10.1021/acsinfecdis.0c00102
Open DOI Search in Google Scholar Back to article
Chen Y, Xiang Q, Liu L. Comparison of antibiotic-associated diarrhea caused by cefoperazone/sulbactam or piperacillin/tazobactam in neurosurgery patients. J Int Med Res. 2021 May;49(5): 3000605211019661. https://doi.org/10.1177/03000605211019661
Open DOI Search in Google Scholar Back to article
CLSI. Performance standards for antimicrobial susceptibility testing. 30th ed. CLSI supplement M100. Wayne (USA): Clinical and Laboratory Standards Institute; 2020.
Search in Google Scholar Back to article
Fournier B, Gravel A, Hooper DC, Roy PH. Strength and regulation of the different promoters for chromosomal beta-lactamases of Klebsiella oxytoca. Antimicrob Agents Chemother. 1999 Apr; 43(4): 850–855. https://doi.org/10.1128/AAC.43.4.850
Open DOI Search in Google Scholar Back to article
Han MS, Park KS, Jeon JH, Lee JK, Lee JH, Choi EH, Lee SH. SHV Hyperproduction as a mechanism for piperacillin-tazobactam resistance in extended-spectrum cephalosporin-susceptible Klebsiella pneumoniae. Microb Drug Resist. 2020 Apr;26(4):334–340. https://doi.org/10.1089/mdr.2019.0079
Open DOI Search in Google Scholar Back to article
Hubbard ATM, Mason J, Roberts P, Parry CM, Corless C, van Aartsen J, Howard A, Bulgasim I, Fraser AJ, Adams ER, et al. Piperacillin/tazobactam resistance in a clinical isolate of Escherichia coli due to IS26-mediated amplification of blaTEM-1B. Nat Commun. 2020 Oct 1;11(1):4915. https://doi.org/10.1038/s41467-020-18668-2
Open DOI Search in Google Scholar Back to article
Joshi P, Shrivastava R, Bhagwat S, Patel M. Activity of β-lactam plus β-lactam-enhancer combination cefepime/zidebactam against Klebsiella pneumoniae harbouring defective OmpK35/36 porins and carbapenemases. Diagn Microbiol Infect Dis. 2021 Oct;101(2):115481. https://doi.org/10.1016/j.diagmicrobio.2021.115481
Open DOI Search in Google Scholar Back to article
Kashefieh M, Hosainzadegan H, Baghbanijavid S, Ghotaslou R. The molecular epidemiology of resistance to antibiotics among Klebsiella pneumoniae isolates in Azerbaijan, Iran. J Trop Med. 2021 Jul 12;2021:9195184. https://doi.org/10.1155/2021/9195184
Open DOI Search in Google Scholar Back to article
Kuo SC, Wang YC, Tan MC, Huang WC, Shiau YR, Wang HY, Lai JF, Huang IW, Lauderdale TL. In vitro activity of imipenem/ relebactam, meropenem/vaborbactam, ceftazidime/avibactam, cefepime/zidebactam and other novel antibiotics against imipenem-non-susceptible Gram-negative bacilli from Taiwan. J Antimicrob Chemother. 2021 Jul 15;76(8):2071–2078. https://doi.org/10.1093/jac/dkab141
Open DOI Search in Google Scholar Back to article
Martínez-Martínez L. Extended-spectrum beta-lactamases and the permeability barrier. Clin Microbiol Infect. 2008 Jan;14(Suppl 1): 82–89. https://doi.org/10.1111/j.1469-0691.2007.01860.x
Open DOI Search in Google Scholar Back to article
Morroni G, Bressan R, Fioriti S, D’Achille G, Mingoia M, Cirioni O, Di Bella S, Piazza A, Comandatore F, Mauri C, et al. Antimicrobial activity of aztreonam in combination with old and new β-lactamase inhibitors against MBL and ESBL co-producing Gram-Negative clinical isolates: possible options for the treatment of complicated infections. Antibiotics (Basel). 2021 Nov 3;10(11):1341. https://doi.org/10.3390/antibiotics10111341
Open DOI Search in Google Scholar Back to article
Noguchi T, Matsumura Y, Kanahashi T, Tanaka M, Tsuchido Y, Matsumura T, Nakano S, Yamamoto M, Nagao M, Ichiyama S. Role of TEM-1 β-lactamase in the predominance of ampicillin-sulbactam-nonsusceptible Escherichia coli in Japan. Antimicrob Agents Chemother. 2019 Jan 29;63(2):e02366-18. https://doi.org/10.1128/AAC.02366-18
Open DOI Search in Google Scholar Back to article
Paterson DL, Bonomo RA. Extended-spectrum beta-lactamases: A clinical update. Clin Microbiol Rev. 2005 Oct;18(4):657–686. https://doi.org/10.1128/CMR.18.4.657-686.2005
Open DOI Search in Google Scholar Back to article
Ramdani-Bouguessa N, Manageiro V, Jones-Dias D, Ferreira E, Tazir M, Caniça M. Role of SHV β-lactamase variants in resistance of clinical Klebsiella pneumoniae strains to β-lactams in an Algerian hospital. J Med Microbiol. 2011 Jul;60(Pt 7):983–987. https://doi.org/10.1099/jmm.0.030577-0
Open DOI Search in Google Scholar Back to article
Rehman N, Azam S, Ali A, Khan I, Asghar M, Ali M, Waqas M, Ullah F, Sehra GE. Molecular epidemiology of antibiotic-resistant genes and potent inhibitors against TEM, CTX-M-14, CTX-M-15, and SHV-1 proteins of Escherichia coli in district Peshawar, Pakistan. Saudi J Biol Sci. 2021 Nov;28(11):6568–6581. https://doi.org/10.1016/j.sjbs.2021.07.028
Open DOI Search in Google Scholar Back to article
Schechter LM, Creely DP, Garner CD, Shortridge D, Nguyen H, Chen L, Hanson BM, Sodergren E, Weinstock GM, Dunne WM Jr, et al. Extensive gene amplification as a mechanism for piperacillintazobactam resistance in Escherichia coli. mBio. 2018 Apr 24;9(2): e00583-18. https://doi.org/10.1128/mBio.00583-18
Open DOI Search in Google Scholar Back to article
Stewart AG, Price EP, Schabacker K, Birikmen M, Harris PNA, Choong K, Subedi S, Sarovich DS. Molecular epidemiology of third-generation cephalosporin-resistant Enterobacteriaceae in Southeast Queensland, Australia. Antimicrob Agents Chemother. 2021 May 18;65(6):e00130-21. https://doi.org/10.1128/AAC.00130-21
Open DOI Search in Google Scholar Back to article
Sun J, Wang Y, Ni YX. [Hyperproduction of TEM-1 β-lactamase mediates the resistance of Escherichia coli to piperacillin-tazobactam and cefoperazone] (in Chinese). Chin J Infect Chemother. 2013 May;13(3):167–172. https://doi.org/10.16718/j.1009-7708.2013.03.003
Open DOI Search in Google Scholar Back to article
Thomson KS, AbdelGhani S, Snyder JW, Thomson GK. Activity of cefepime-zidebactam against multidrug-resistant (MDR) Gram-Negative pathogens. Antibiotics (Basel). 2019 Mar 23;8(1):32. https://doi.org/10.3390/antibiotics8010032
Open DOI Search in Google Scholar Back to article
Tian X, Wang Q, Perlaza-Jiménez L, Zheng X, Zhao Y, Dhanasekaran V, Fang R, Li J, Wang C, Liu H, Lithgow T, Cao J, Zhou T. First description of antimicrobial resistance in carbapenem-susceptible Klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodeling. BMC Microbiol. 2020 Jul 20;20(1):218. https://doi.org/10.1186/s12866-020-01898-1
Open DOI Search in Google Scholar Back to article
Winkler ML, Papp-Wallace KM, Taracila MA, Bonomo RA. Avibactam and inhibitor-resistant SHV β-lactamases. Antimicrob Agents Chemother. 2015 Jul;59(7):3700–3709. https://doi.org/10.1128/AAC.04405-14
Open DOI Search in Google Scholar Back to article
Zhou K, Tao Y, Han L, Ni Y, Sun J. Piperacillin-tazobactam (TZP) resistance in Escherichia coli due to hyperproduction of TEM-1 β-Lactamase mediated by the promoter Pa/Pb. Front Microbiol. 2019 Apr 16;10:833. https://doi.org/10.3389/fmicb.2019.00833
Open DOI Search in Google Scholar Back to article

Diminished Susceptibility to Cefoperazone/Sulbactam and Piperacillin/Tazobactam in Enterobacteriaceae Due to Narrow-Spectrum β-Lactamases as Well as Omp Mutation

Abstract

Paradigm

My account